Stryker had two patents in mobile during Q1 2024. Stryker Corp’s patent for a wound closure apparatus includes two panels with adhesive, substrate, and load distribution layers, as well as a sensory or therapeutic element for monitoring and customizing therapy for the incision. GlobalData’s report on Stryker gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Stryker grant share with mobile as a theme is 50% in Q1 2024. Grant share is based on the ratio of number of grants to total number of patents.
Recent Patents
Application: Instrumented wound closure device (Patent ID: US20240065621A1)
The wound or incision closure apparatus described in the patent by Stryker Corp consists of two panels with adhesive layers, substrate layers, and load distribution layers. These panels are used to close wounds or incisions by drawing the lateral sides together. The apparatus also includes a sensory or therapeutic element that can provide therapy to the patient and monitor the incision for customization and updates.
The method outlined in the patent involves adhering the panels to the sides of the wound, drawing them together laterally, and providing therapy using a therapeutic element within the panels. Additionally, the method includes sensing physiological parameters with a sensory element, which can be used for various therapies such as phototherapy, vibration therapy, drug delivery, and more. The sensed physiological parameters can be transmitted to external receiving devices like workstations, computers, smartphones, or wearable devices for monitoring and analysis.
To know more about GlobalData’s detailed insights on Stryker, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.